Physician profile
Benjamin Holmes
NPI 1093072654
$14,602.97
in general payments reported to CMS, 2019-2025
30 companies · $2,150 in 2025
The $2,150 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,836 · 2021: $1,957 · 2022: $2,702 · 2023: $3,694 · 2024: $2,265 · 2025: $2,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,897 · Travel and Lodging: $3,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,897.39 |
| Travel and Lodging | $3,210.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,547.60 | 2020-2025 | Gallant, Aveir, Ensite |
| Boston Scientific Corporation | $3,516.86 | 2020-2024 | Watchman Flx, Watchman Access System, Watchman |
| Biosense Webster, INC. | $3,318.15 | 2020-2025 | Carto 3, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $1,679.91 | 2023 | Carto 3 |
| Medtronic, INC. | $1,522.18 | 2021-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Micra |
| Novartis Pharmaceuticals Corporation | $150.87 | 2021-2024 | |
| Abiomed | $124.42 | 2022 | |
| Atricure, INC. | $92.27 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.82 | 2023-2024 | Lifevest |
| Cordis US Corp. | $67.91 | 2025 | Mynx Control |
| Cardiva Medical, INC. | $58.61 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $43.53 | 2020-2023 | Farxiga |
| Cvrx, INC. | $37.74 | 2023 | Barostim Neo System |
| Altathera Pharmaceuticals LLC | $37.46 | 2021-2022 | |
| Novo Nordisk INC | $36.22 | 2022-2023 | Ozempic, Rybelsus |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $28.90 | 2020 | |
| Pfizer INC. | $28.11 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $27.20 | 2021-2024 | Eliquis |
| Innovation Technologies INC | $25.66 | 2022 | |
| Daiichi Sankyo INC. | $23.33 | 2022 | |
| Biotronik INC. | $19.41 | 2022 | |
| Edwards Lifesciences Corporation | $18.62 | 2021 | |
| Ethicon US, LLC | $18.19 | 2023 | Ethicon, Stratafix, Dermabond |
| Kiniksa Pharmaceuticals International, Plc | $17.10 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $16.17 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $16.08 | 2024 | |
| Angiodynamics, INC. | $15.64 | 2021 | |
| Convatec INC. | $14.45 | 2022 | |
| Cardiovascular Systems INC. | $14.30 | 2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $14.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.